Acrux eyes best day in 3 wks on US FDA nod for new drug application

Acrux

04/07/2023 03:45

** Shares of Australia's Acrux Ltd  ACR.AX  rise as much as
9.5% to A$0.046, set to mark best day since June 13, if current
gains hold 
    ** Stock hits highest since June 26  
    ** Pharmaceutical co says U.S. Food and Drug Administration
has accepted co's abbreviated new drug application for a generic
version of Nitroglycerin generic, 0.4% 
    ** Drug used to treat moderate to severe pain associated
with chronic anal fissure   
    ** Stock has fallen 40% this year, as of last close

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))